Shopping Cart
- Remove All
- Your shopping cart is currently empty
SB-218078 is less potently inhibits Cdc2 (IC50: 250 nM) and PKC (IC50: 1000 nM). SB-218078 is a potent, ATP-competitive, and cell-permeable checkpoint kinase 1 inhibitor that inhibits Chk1 phosphorylation of cdc25C (IC50: 15 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $353 | 35 days |
Description | SB-218078 is less potently inhibits Cdc2 (IC50: 250 nM) and PKC (IC50: 1000 nM). SB-218078 is a potent, ATP-competitive, and cell-permeable checkpoint kinase 1 inhibitor that inhibits Chk1 phosphorylation of cdc25C (IC50: 15 nM). |
Targets&IC50 | Chk1:15 nM, CDC2:250 nM, PKC:1000 nM, Apoptosis: |
In vitro | SB-218078 (500-625 μM; 96 hours; HeLa and HT-29 cells) treatment obviously enhances the cytotoxicity of DNA damage. SB-218078 (2.5-5 μM; 18 hours; HeLa cells) treatment abrogates G2 cell cycle arrest caused by either γ-irradiation or a topoisomerase I Topotecan inhibition [1]. |
In vivo | SB-218078 (5 mg/kg; intraperitoneal injection; for 16 hours; C57/Bl6 mice) treatment significantly induces γ-H2AX levels and apoptosis in lymphoma [2]. |
Molecular Weight | 393.39 |
Formula | C24H15N3O3 |
Cas No. | 135897-06-2 |
Relative Density. | 1.80 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.